Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhancedT1-weighted MRI

article

Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhancedT1-weighted MRI is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/MRM.10080
P698PubMed publication ID11870848

P50authorDavid BuckleyQ42855553
P2093author name stringDavid L. Buckley
P2860cites workModeling cerebral blood flow and flow heterogeneity from magnetic resonance residue dataQ30578197
Direct comparison of an intravascular and an extracellular contrast agent for quantification of myocardial perfusion. Cardiac MRI GroupQ30591279
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.Q33744660
Modeling tracer kinetics in dynamic Gd-DTPA MR imagingQ41352795
Tracer-kinetic models for measuring cerebral blood flow using externally detected radiotracersQ48224800
An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivationQ48331032
Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental conceptsQ48797418
Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumorsQ48884217
Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition.Q52074468
Noninvasive assessment of the functional neovasculature in 9L-glioma growing in rat brain by dynamic 1H magnetic resonance imaging of gadolinium uptake.Q52539380
Temporal sampling requirements for the tracer kinetics modeling of breast disease.Q52906866
Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumoursQ56589759
Microvessel density in invasive breast cancer assessed by dynamic gd-dtpa enhanced MRIQ56589987
P433issue3
P921main subjectmagnetic resonance imagingQ161238
P304page(s)601-606
P577publication date2002-03-01
P1433published inMagnetic Resonance in MedicineQ6731496
P1476titleUncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI
P478volume47

Reverse relations

cites work (P2860)
Q51682947A comparison of Ktrans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas.
Q44337183A unified impulse response model for DCE-MRI.
Q33997699Accuracy of perfusion MRI with high spatial but low temporal resolution to assess invasive breast cancer response to neoadjuvant chemotherapy: a retrospective study.
Q45840193Analysis of parametric histogram from dynamic contrast-enhanced MRI: application in evaluating brain tumor response to radiotherapy
Q36417718Arterial spin-labeling MR imaging of renal masses: correlation with histopathologic findings
Q36750627Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI.
Q48226842Assessment of vessel permeability by combining dynamic contrast-enhanced and arterial spin labeling MRI.
Q92875613Biopsy Confirmed Glioma Recurrence Predicted by Multi-Modal Neuroimaging Metrics
Q39387171Blind estimation of the arterial input function in dynamic contrast-enhanced MRI using purity maximization
Q35015049Can DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model?
Q35946168Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI
Q55471802Comparative study of methods for determining vascular permeability and blood volume in human gliomas.
Q36120153Comparison of Cerebral Blood Volume and Plasma Volume in Untreated Intracranial Tumors
Q51965252Comprehensive model for simultaneous MRI determination of perfusion and permeability using a blood-pool agent in rats rhabdomyosarcoma.
Q45860260Computer assisted analysis of MR-mammography reveals association between contrast enhancement and occurrence of distant metastasis
Q36103551Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas
Q35170356Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion.
Q38074638Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies
Q33507482Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging
Q33552489Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy
Q33510695Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples
Q36258939Dynamic Contrast-Enhanced MRI in the Study of Brain Tumors. Comparison Between the Extended Tofts-Kety Model and a Phenomenological Universalities (PUN) Algorithm
Q37684706Dynamic Contrast-Enhanced Magnetic Resonance Enterography and Dynamic Contrast-Enhanced Ultrasonography in Crohn's Disease: An Observational Comparison Study.
Q41000474Dynamic Contrast-Enhanced Perfusion MRI of High Grade Brain Gliomas Obtained with Arterial or Venous Waveform Input Function
Q38725827Dynamic contrast-enhanced MRI for oncology drug development
Q37983692Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies
Q51065208Dynamic contrast-enhanced MRI in mice: an investigation of model parameter uncertainties.
Q30456007ESR statement on the stepwise development of imaging biomarkers
Q51703095Estimation of tissue perfusion by dynamic contrast-enhanced imaging: simulation-based evaluation of the steepest slope method.
Q51593516Extended graphical model for analysis of dynamic contrast-enhanced MRI.
Q34550986Fast, reproducible measurement of the vascular input function in mice using constrained reconstruction and cardiac sampling.
Q35116981Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging
Q45981337Glucosamine sulfate effect on the degenerated patellar cartilage: preliminary findings by pharmacokinetic magnetic resonance modeling.
Q45968202High temporal resolution 3D gadolinium-enhanced dynamic MR imaging of renal tumors with pharmacokinetic modeling: preliminary observations.
Q35625666High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI.
Q34203930Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours
Q36464131Imaging heterogeneity of peptide delivery and binding in solid tumors using SPECT imaging and MRI
Q51573923Imaging microvascular structure with contrast enhanced MRI.
Q31144032Imaging of angiogenesis: from microscope to clinic
Q89427753Impact of contrast agent injection duration on dynamic contrast-enhanced MRI quantification in prostate cancer
Q30579313Impact of transvascular and cellular-interstitial water exchange on dynamic contrast-enhanced magnetic resonance imaging estimates of blood to tissue transfer constant and blood plasma volume.
Q38902139In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats.
Q31153802Incorporating a vascular term into a reference region model for the analysis of DCE-MRI data: a simulation study
Q51657981Kinetic Models for Cancer Imaging
Q37270567MR imaging of the prostate in clinical practice
Q35905005MRI for assessing antivascular cancer treatments
Q92672901Machine learning classifiers can predict Gleason pattern 4 prostate cancer with greater accuracy than experienced radiologists
Q33436273Magnetic resonance imaging as a biomarker in renal cell carcinoma
Q37436294Magnetic resonance imaging defines cervicovaginal anatomy, cancer, and VEGF trap antiangiogenic efficacy in estrogen-treated K14-HPV16 transgenic mice.
Q30479156Magnetic resonance perfusion imaging in neuro-oncology.
Q30442598Markers of cochlear inflammation using MRI.
Q33711249Measurement of blood-brain barrier permeability with t1-weighted dynamic contrast-enhanced MRI in brain tumors: a comparative study with two different algorithms.
Q45343210Modeling DCE-MRI at low temporal resolution: a case study on rheumatoid arthritis
Q38282639Models and methods for analyzing DCE-MRI: a review.
Q34203974Multicentre imaging measurements for oncology and in the brain.
Q34538659Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancer
Q38774733Multiphasic contrast injection for improved precision of parameter estimates in functional CT.
Q37876335New acquisition techniques: fields of application
Q64067937Noninvasive monitoring of blood flow using a single magnetic microsphere
Q46265644On the scope and interpretation of the Tofts models for DCE-MRI.
Q38860709Optimization of arterial spin labeling MRI for quantitative tumor perfusion in a mouse xenograft model.
Q43464254Optimized pharmacokinetic modeling for the detection of perfusion differences in skeletal muscle with DCE-MRI: effect of contrast agent size
Q57298860Parameterized level-set based pharmacokinetic fluorescence optical tomography using the regularized Gauss-Newton filter
Q47322697Performance of Ultrafast DCE-MRI for Diagnosis of Prostate Cancer.
Q37749568Perfusion MRI in the early clinical development of antivascular drugs: decorations or decision making tools?
Q27012911Perfusion magnetic resonance imaging: a comprehensive update on principles and techniques
Q33703176Pharmacokinetic analysis of tissue microcirculation using nested models: multimodel inference and parameter identifiability
Q49076621Precision analysis of kinetic modelling estimates in dynamic contrast enhanced MRI.
Q51411292Quantification of pulmonary microcirculation by dynamic contrast-enhanced magnetic resonance imaging: comparison of four regularization methods.
Q33911988Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma
Q31138977Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer
Q92489166Reliability of dynamic contrast-enhanced magnetic resonance imaging data in primary brain tumours: a comparison of Tofts and shutter speed models
Q42917550Reproducibility of the gadolinium concentration measurements and of the fitting parameters of the vascular input function in the superior sagittal sinus in a patient population
Q34367593Review of treatment assessment using DCE-MRI in breast cancer radiation therapy
Q35110740Semi-quantitative parameter analysis of DCE-MRI revisited: monte-carlo simulation, clinical comparisons, and clinical validation of measurement errors in patients with type 2 neurofibromatosis.
Q35215149Simulation study of the effect of golden-angle KWIC with generalized kinetic model analysis on diagnostic accuracy for lesion discrimination
Q46863259Simulation-based comparison of two approaches frequently used for dynamic contrast-enhanced MRI.
Q38764089Simultaneous measurement of T1 /B1 and pharmacokinetic model parameters using active contrast encoding (ACE)-MRI.
Q37049919Statistical Learning Algorithm for in situ and invasive breast carcinoma segmentation
Q30775286Steady-state and dynamic contrast MR imaging of human prostate cancer xenograft tumors: a comparative study
Q42123025Suppression of vascular enhancement artifacts through the use of a multiband, selectively spoiled radiofrequency excitation pulse
Q33660443Temporal resolution and SNR requirements for accurate DCE-MRI data analysis using the AATH model
Q33534774The influence of temporal resolution in determining pharmacokinetic parameters from DCE-MRI data
Q34635573The use of dynamic tracer concentration in veins for quantitative DCE-MRI kinetic analysis in head and neck.
Q30873526The use of error-category mapping in pharmacokinetic model analysis of dynamic contrast-enhanced MRI data.
Q31136105Theoretical basis of hemodynamic MR imaging techniques to measure cerebral blood volume, cerebral blood flow, and permeability
Q33800926Three-dimensional dynamic contrast enhanced imaging of the carotid artery with direct arterial input function measurement.
Q42606877Tissue-specific compartmental analysis for dynamic contrast-enhanced MR imaging of complex tumors.
Q37760857Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements
Q36421776Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments
Q37995577Tumor response assessments with diffusion and perfusion MRI.
Q47104951TumourMetrics: a comprehensive clinical solution for the standardization of DCE-MRI analysis in research and routine use.
Q33664381Ultrafast 3D spin-echo acquisition improves Gadolinium-enhanced MRI signal contrast enhancement
Q33951156Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences
Q45401985Uncertainty estimation in dynamic contrast-enhanced MRI.
Q30665072Uncertainty in MR tracer kinetic parameters and water exchange rates estimated from T1-weighted dynamic contrast enhanced MRI
Q36264886Validation of Blood Volume Fraction Quantification with 3D Gradient Echo Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Porcine Skeletal Muscle.
Q46640157Validity of perfusion parameters obtained using the modified Tofts model: a simulation study
Q80212243[Magnetic resonance imaging of angiogenesis in tumors]

Search more.